Researchers Identify Best Drug Therapy for Rare, Aggressive Pancreatic Cancer


Each year, about 200 to 400 Americans develop acinar cell carcinoma, a rare form of pancreatic cancer that has no effective standard of care. John A. Copland, III, Ph.D., discusses a study involving researchers on Mayo Clinic’s campuses in Jacksonville, Florida, and Rochester, Minnesota, who found that the chemotherapy drug oxaliplatin is effective in stopping the growth of this cancer.